Latest news
RBC Capital Adjusts PT on Shift4 Payments to $63 From $65, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 17:33:05 GMTRBC Capital Adjusts PT on DuPont De Nemours to $176 From $180, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 15:53:31 GMTRBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:05:17 GMTRBC Adjusts PT on First Advantage to $24 From $21, Maintains Sector Perform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:50:19 GMTRBC Capital Adjusts Victory Capital PT to $118 From $107, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:49:52 GMTRBC Adjusts PT on Praxis Precision Medicines to $462 From $449, Keeps Outperform Speculative Risk Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:45:51 GMTRBC Adjusts PT on Traeger to $43 From $37.50, Maintains Sector Perform Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:39:02 GMTRBC Capital Adjusts Watts Water Technologies PT to $417 From $350, Maintains Sector Perform Rating - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:27:38 GMT